Members |
targetComponentId |
Ceftazidime 2gm/vil powder |
Ceftazidime 2 g powder for solution for injection vial |
Ceftazidime 500mg infusion solution vial |
Ceftazidime 500 mg powder for solution for injection vial |
Ceftazidime 500mg injection |
Ceftazidime 500 mg powder for solution for injection vial |
Ceftazidime 500mg/vial injection |
Ceftazidime 500 mg powder for solution for injection vial |
ceftazidimpentahydrat 100 mg, infusionsvätska, lösning, flaska |
Ceftazidime only product in parenteral dose form |
Ceftazidime pentahydrate 1g injection |
Ceftazidime only product in parenteral dose form |
Ceftazidime pentahydrate 1g/vial injection |
Ceftazidime only product in parenteral dose form |
Ceftazidime pentahydrate 2g injection |
Ceftazidime 2 g powder for solution for injection vial |
Ceftazidime pentahydrate 2g powder for injection |
Ceftazidime 2 g powder for solution for injection vial |
Ceftazidime pentahydrate 2g/vial injection |
Ceftazidime 2 g powder for solution for injection vial |
ceftazidimpentahydrat 6 g, injektionsvätska, lösning, flaska |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Ceftazidime pentahydrate 6g injection |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Ceftazidime pentahydrate 6g/vial injection |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Ceftazidime sodium 1g injection |
Ceftazidime 1 g powder for solution for injection vial |
Ceftazidime sodium 1g powder for injection |
Ceftazidime 1 g powder for solution for injection vial |
Ceftazidime sodium 2g injection |
Ceftazidime 2 g powder for solution for injection vial |
Ceftazidime sodium 2g powder for injection |
Ceftazidime 2 g powder for solution for injection vial |
ceftazidimnatrium 2 g/50 ml, infusionsvätska, lösning, påse 50 ml |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Ceftazidime sodium 2g/50 mL injection |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
ceftazidimnatrium 2 g/50 ml, intravenös vätska, lösning, påse 50 ml |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Ceftazidime sodium 2g/50mL injection |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
natriumceftizoxim 10 g, pulver till injektionsvätska, flaska |
Product containing precisely ceftizoxime (as ceftizoxime sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
natriumceftizoxim 1 g, pulver till injektionsvätska, flaska |
Product containing precisely ceftizoxime (as ceftizoxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
natriumceftizoxim 2 g, pulver till injektionsvätska, flaska |
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial |
Ceftizoxime sodium 2g/vial injection |
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial |
natriumceftizoxim 500 mg, pulver till injektionsvätska, flaska |
Ceftizoxime (as ceftizoxime sodium) 500 mg powder for solution for injection vial |
natriumceftriaxon 10 g, pulver till injektionsvätska, flaska |
Product containing precisely ceftriaxone (as ceftriaxone sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
cefuroximnatrium 15 mg/ml, injektionsvätska, lösning, påse 50 ml |
Product containing precisely cefuroxime (as cefuroxime sodium) 15 milligram/1 milliliter conventional release solution for injection (clinical drug) |
cefuroximnatrium 30 mg/ml, injektionsvätska, lösning, påse 50 ml |
Cefuroxime (as cefuroxime sodium) 30 mg/mL solution for injection |
Celecoxib |
Celecoxib |
Celluella pygmaea |
Callithrix pygmaea (organism) |
Cellulitis of foot, except toe |
Cellulitis of foot |
Cellulitis of head, except face |
Cellulitis of head |
Cellulomonas cellulans |
Cellulosimicrobium cellulans (organism) |
Cellulomonas fermentans |
Actinotalea fermentans (organism) |
natriumcellulosafosfat 300 mg/flaska, pulver för oral suspension |
Cellulose only product in oral dose form |
Central cervical cord injury, without bony injury, C1-4 |
Central cervical cord injury, without spinal bony injury, C1-4 (disorder) |
Central cervical cord injury, without bony injury, C5-7 |
Central cervical cord injury, without spinal bony injury, C5-7 (disorder) |
centralt ryggmärgssyndrom i cervikala ryggmärgen |
Central cord syndrome |
centralt andningsstimulerande medel |
Respiratory stimulant (substance) |
centralt sömnapnésyndrom orsakat av substans |
Central sleep apnea syndrome |
infektion i blodomloppet relaterad till central venkateter |
Infection of bloodstream co-occurrent and due to central venous catheter in situ (disorder) |
infektion i blodomloppet relaterad till central venkateter |
Infection of bloodstream co-occurrent and due to central venous catheter in situ (disorder) |
Central venous catheter: [attention] or [removal Hickman] |
Removal of central venous line |
centrencefal epilepsi |
Generalized epilepsy |
Centruroides sculpturatus |
Centruroides exilicauda |
dysfunktion i kefal del av os pubis |
Superior pubic shear (finding) |
cefalexin 125 mg/5 ml, sirap |
Cefalexin 25 mg/mL oral solution |
cefalexin 250 mg/5 ml, sirap |
Cefalexin anhydrous (as cefalexin) 50 mg/mL oral solution |
Cephalexin monohydrate 250mg capsule |
Product containing precisely cefalexin 250 milligram/1 each conventional release oral capsule (clinical drug) |
Cephalexin monohydrate 500mg capsule |
Cefalexin 500 mg oral capsule |
Cephalic presentation |
Cephalic fetal presentation |
vändning av foster till huvudbjudning |
External cephalic version |
Cephalophus doria |
Cephalophus zebra (organism) |
Cephalotrichium |
Genus Strobilidium (organism) |
cefapirinnatrium 1 g, pulver till injektionsvätska, flaska |
Product containing precisely cefapirin (as cefapirin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Cercospora apii |
Mycocentrospora acerina |
Cerebellar contusion with open intracranial wound and unspecified state of consciousness |
Cerebellar contusion with open intracranial wound |
Cerebellar contusion without open intracranial wound and with unspecified state of consciousness |
Cerebellar contusion without open intracranial wound |
Cerebellar laceration with open intracranial wound and unspecified state of consciousness |
Cerebellar laceration with open intracranial wound |
Cerebellar laceration without open intracranial wound and with unspecified state of consciousness |
Cerebellar laceration without open intracranial wound |
Cerebral degeneration |
Degenerative brain disorder |
Cerebral edema |
Cerebral edema |
syndrom med cerebral gigantism och käkcystor |
Gorlin syndrome |
Cerebrocardiac neurosis |
Neurocirculatory asthenia |
cerebroretinal vaskulopati |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
årlig kontroll av stroke eller cerebrovaskulär händelse |
Cerebrovascular accident annual review |
Certoparin sodium |
Product containing certoparin (medicinal product) |
Ceruloplasmin |
Ferroxidase |
Cervical approach |
Transcervical approach - uterine |
cervikal diskografi |
Discography with injection of contrast into intervertebral disc of cervical spine |
cervikal lambå |
Flap (substance) |
lambå i cervikalregionen |
Flap (substance) |
Cervical smear biopsy taken |
Sampling of cervix for Papanicolaou smear done (situation) |
cervixutstryk taget |
Sampling of cervix for Papanicolaou smear done (situation) |
cervixutstryk, avböjt |
Screening for malignant neoplasm of cervix declined (situation) |
Cervical smear refused |
Screening for malignant neoplasm of cervix declined (situation) |
Cervical smear refused |
Screening for malignant neoplasm of cervix declined (situation) |
Cervical spondylosis with myelopathy |
Myelopathy due to cervical spondylosis (disorder) |
cervikal spondylos med myelopati |
Myelopathy due to cervical spondylosis (disorder) |
cervikal spondylos med radikulopati |
Radiculopathy due to cervical spondylosis (disorder) |
Cervical syndrome, NEC |
Cervical syndrome |
Cervicitis |
Inflammation of cervix |
cervikohumeral fasciokutan lambå |
Fasciocutaneous flap |
Cervus elaphus bactrianus |
Cervus elaphus |
Cervus elaphus nannodes |
Cervus elaphus |
kejsarsnitt, barnet framfött |
Deliveries by caesarean |
Cesarean delivery NOS |
Deliveries by caesarean |
Cesarean delivery unspecified |
Deliveries by caesarean |
Cesarean delivery without indication |
Cesarean section |
cetirizinhydroklorid + pseudoefedrin 5 mg/120 mg, tablett med modifierad frisättning |
Product containing only cetirizine and pseudoephedrine in oral dose form (medicinal product form) |
cetirizinhydroklorid 5 mg + pseudoefedrin 120 mg, depåtablett |
Product containing only cetirizine and pseudoephedrine in oral dose form (medicinal product form) |
cetirizinhydroklorid 5 mg/5 ml, sirap |
Cetirizine hydrochloride 1 mg/mL oral solution |
Cetirizine hydrochloride 5mg/5mL syrup |
Cetirizine hydrochloride 1 mg/mL oral solution |
Cetirizine hydrochloride+pseudoephedrine hydrochloride 5mg/120mg m/r tablet |
Product containing only cetirizine and pseudoephedrine in oral dose form (medicinal product form) |
cetylalkohol 12 mg + kolfoscerilpalmitat 108 mg + tyloxapol 8 mg, pulver |
Product containing only cetyl alcohol and colfosceril and tyloxapol (medicinal product) |
cetyldimetikon 5 %, badolja |
Cetyl dimeticone 50 mg/mL cutaneous oil |
utmanande miljö |
Challenging environment |
kamomillextrakt 10,5 %, salva |
Product containing only chamomile extract (medicinal product) |
Chancre of yaws |
Initial lesion of yaws |
schankriformt syndrom |
Cutaneous coccidioidomycosis |